Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19?

Bulbus fritillariae cirrhosae (BFC) is one of the most used Chinese medicines for lung disease, and exerts antitussive, expectorant, anti-inflammatory, anti-asthmatic, and antioxidant effects, which is an ideal therapeutic drug for respiratory diseases such as ARDS, COPD, asthma, lung cancer, and pu...

Full description

Saved in:
Bibliographic Details
Main Authors: Yunyun Quan (Author), Li Li (Author), Zhujun Yin (Author), Shilong Chen (Author), Jing Yi (Author), Jirui Lang (Author), Lu Zhang (Author), Qianhua Yue (Author), Junning Zhao (Author)
Format: Book
Published: Frontiers Media S.A., 2022-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_cfcb09cfd6074a49b091c2f3c6e29ddf
042 |a dc 
100 1 0 |a Yunyun Quan  |e author 
700 1 0 |a Yunyun Quan  |e author 
700 1 0 |a Li Li  |e author 
700 1 0 |a Zhujun Yin  |e author 
700 1 0 |a Shilong Chen  |e author 
700 1 0 |a Jing Yi  |e author 
700 1 0 |a Jirui Lang  |e author 
700 1 0 |a Lu Zhang  |e author 
700 1 0 |a Qianhua Yue  |e author 
700 1 0 |a Junning Zhao  |e author 
700 1 0 |a Junning Zhao  |e author 
245 0 0 |a Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19? 
260 |b Frontiers Media S.A.,   |c 2022-01-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2021.784335 
520 |a Bulbus fritillariae cirrhosae (BFC) is one of the most used Chinese medicines for lung disease, and exerts antitussive, expectorant, anti-inflammatory, anti-asthmatic, and antioxidant effects, which is an ideal therapeutic drug for respiratory diseases such as ARDS, COPD, asthma, lung cancer, and pulmonary tuberculosis. Through this review, it is found that the therapeutic mechanism of BFC on respiratory diseases exhibits the characteristics of multi-components, multi-targets, and multi-signaling pathways. In particular, the therapeutic potential of BFC in terms of intervention of "cytokine storm", STAT, NF-κB, and MAPK signaling pathways, as well as the renin-angiotensin system (RAS) that ACE is involved in. In the "cytokine storm" of SARS-CoV-2 infection there is an intense inflammatory response. ACE2 regulates the RAS by degradation of Ang II produced by ACE, which is associated with SARS-CoV-2. For COVID-19, may it be a potential drug? This review summarized the research progress of BFC in the respiratory diseases, discussed the development potentiality of BFC for the treatment of COVID-19, explained the chemical diversity and biological significance of the alkaloids in BFC, and clarified the material basis, molecular targets, and signaling pathways of BFC for the respiratory diseases. We hope this review can provide insights on the drug discovery of anti-COVID-19. 
546 |a EN 
690 |a bulbus fritillariae cirrhosae 
690 |a alkaloids 
690 |a respiratory diseases 
690 |a signaling pathways 
690 |a targets 
690 |a COVID-19 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 12 (2022) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2021.784335/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/cfcb09cfd6074a49b091c2f3c6e29ddf  |z Connect to this object online.